Sanofi’s vaccine tech transfer in Vietnam; Almac’s £1B+ revenue milestonenews2025-05-29T14:03:26+00:00May 29th, 2025|Endpoints News|
FDA rejects Stealth’s rare disease drug, but offers potential for accelerated approvalnews2025-05-29T11:14:27+00:00May 29th, 2025|Endpoints News|
Novo Nordisk ‘strongly’ urges US away from pharma tariffsnews2025-05-28T17:46:09+00:00May 28th, 2025|Endpoints News|
FDA rejects Savara’s rare lung disease drug over limited manufacturing datanews2025-05-27T17:04:35+00:00May 27th, 2025|Endpoints News|
FDA names acting head of inspections; J&J again advocates for tax policies as alternative to tariffsnews2025-05-22T16:28:32+00:00May 22nd, 2025|Endpoints News|
Pharma companies consider ‘first sale’ rule to ease tariff impactnews2025-05-22T15:35:10+00:00May 22nd, 2025|Endpoints News|
Samsung Biologics to separate manufacturing and biosimilar businessesnews2025-05-22T10:50:18+00:00May 22nd, 2025|Endpoints News|
FDA announces efforts to facilitate drug importation from Canada news2025-05-21T20:02:27+00:00May 21st, 2025|Endpoints News|
Mark Cuban compounder joins Trump’s new manufacturing initiativenews2025-05-16T15:15:19+00:00May 16th, 2025|Endpoints News|
Top RFK Jr. advisor dares drugmakers over threats to drop manufacturing promisesnews2025-05-15T22:36:16+00:00May 15th, 2025|Endpoints News|
